1 |
Risankizumab |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 96, 97, 271 💬 |
2 |
Risankizumab (genetical recombination) |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 1件: 97 💬 |
3 |
Risankizumab 10 mg/ml |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
4 |
Risankizumab 180 mg sc |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
5 |
Risankizumab 600 mg iv |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
6 |
Risankizumab 90 mg/ml |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
7 |
Risankizumab iv |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
8 |
Risankizumab sc |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |